novo nordisk glp 1 drugs Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment Novo Nordisk Drops Hims &

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets

Qatar Biobank This study was based on the second release of 14,060 Qatari participants (all from the same ancestry, MID) from the population-based Qatar Genome Program (QGP)

Gastroenterology 132 , 21312157 (2007)

In recent years, off-label use for weight loss has contributed to GLP-1 RAs shortages, limiting access for patients with diabetes

Insulin glargine (U-100)/lixisenatide: Insulin glargine/lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D